100 related articles for article (PubMed ID: 4088282)
1. Chlorophenoxyisobutyric acid derivatives and apolipoprotein B metabolism.
Shepherd J; Packard CJ
Monogr Atheroscler; 1985; 13():85-91. PubMed ID: 4088282
[No Abstract] [Full Text] [Related]
2. [Clinical and therapeutic evaluation of a new antilipemic substance].
de Aguiar Magano L
Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
[TBL] [Abstract][Full Text] [Related]
3. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
[TBL] [Abstract][Full Text] [Related]
4. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Gustafson A
Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950
[No Abstract] [Full Text] [Related]
5. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
[TBL] [Abstract][Full Text] [Related]
6. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
Hanefeld M; Schulze J; Fritz T; Kemmer C
Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
[No Abstract] [Full Text] [Related]
7. [Comparative studies on the reduction of lipids using clofibric acid and clofibrate in hyperlipoproteinemias].
Schwartzkopff W; Hoffmann H; Kästner W
Med Welt; 1975 Dec; 26(51):2308-15. PubMed ID: 177837
[No Abstract] [Full Text] [Related]
8. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
Maroto ML; Priego JG; Piña M; Catalán RE
Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
[No Abstract] [Full Text] [Related]
9. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
[TBL] [Abstract][Full Text] [Related]
10. [Current trends in the therapy of arteriosclerotic disease].
Toscano S
G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
[No Abstract] [Full Text] [Related]
11. [Influence of etofibrate on plasmaviscosity in hyperlipoproteinemias (author's transl)].
Pfeiffer M; Tilsner V
Med Klin; 1978 Jan; 73(2):60-2. PubMed ID: 622057
[No Abstract] [Full Text] [Related]
12. [The treatment of essential hyperlipidemia with clofibrate].
Reuter W; Seifert A
Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
[No Abstract] [Full Text] [Related]
13. [Arteriosclerosis--nicotinic acid therapy. 2. Alterations in serum lipoproteins. Diagnosis, therapy].
Gustafson A
Lakartidningen; 1971 Apr; 68(15):1744-5 passim. PubMed ID: 5577244
[No Abstract] [Full Text] [Related]
14. Serum cholesterol and triglycerides.
Myant NB
Practitioner; 1973 Aug; 211(262):188-92. PubMed ID: 4728419
[No Abstract] [Full Text] [Related]
15. Altering lipid patterns in adult males.
Appelbaum JJ; Amundsen MA; Perkin DK
J Occup Med; 1974 Aug; 16(8):539-42. PubMed ID: 4367267
[No Abstract] [Full Text] [Related]
16. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
Sterner W; Schultz A
Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
[No Abstract] [Full Text] [Related]
17. Effect of bezafibrate on the high-density lipoprotein subfractions HDL2 and HDL3 in primary hyperlipoproteinemia type IV.
Schwandt P; Weisweiler P
Artery; 1980; 7(6):464-70. PubMed ID: 7236016
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
Sterner W; Chibanguza G; Metz G
Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056
[TBL] [Abstract][Full Text] [Related]
19. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
Malhotra SC; Ahuja MM
Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000
[No Abstract] [Full Text] [Related]
20. [Diagnosis and therapy of symptomatic and essential hyperlipidemia].
Dabels J
Z Gesamte Inn Med; 1971 Apr; 26(8):261-5. PubMed ID: 5565821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
